The Abramson Cancer Center of the University of Pennsylvania
Last Modified: July 10, 2002
Nov 2, 2010 - Most recent oncology randomized controlled trials evaluate drugs that are available "off-protocol therapy" in the United States, and this can adversely impact trial enrollment, according to a study published online Oct. 25 in the Journal of Clinical Oncology.
Nov 2, 2010
Jul 31, 2014
Nov 30, 2010